For research use only. Not for therapeutic Use.
GLUT1-IN-2（Cat No.:I042630）is an investigational small molecule inhibitor designed to target and inhibit the GLUT1 (glucose transporter 1) protein, which is responsible for the uptake of glucose into cells. GLUT1 plays a crucial role in maintaining glucose homeostasis, especially in tissues with high metabolic demands, such as the brain and cancer cells. Overexpression of GLUT1 is often associated with various cancers, as tumor cells require more glucose for rapid growth. GLUT1-IN-2 is being studied for its potential therapeutic applications in cancer treatment, aiming to limit glucose availability to tumors and slow their progression.
| CAS Number | 305357-89-5 |
| Synonyms | N-[3-(1H-benzimidazol-2-yl)phenyl]-3-methylbenzamide |
| Molecular Formula | C21H17N3O |
| Purity | ≥95% |
| IUPAC Name | N-[3-(1H-benzimidazol-2-yl)phenyl]-3-methylbenzamide |
| InChI | InChI=1S/C21H17N3O/c1-14-6-4-8-16(12-14)21(25)22-17-9-5-7-15(13-17)20-23-18-10-2-3-11-19(18)24-20/h2-13H,1H3,(H,22,25)(H,23,24) |
| InChIKey | BFAZKDZNMRHORZ-UHFFFAOYSA-N |
| SMILES | CC1=CC(=CC=C1)C(=O)NC2=CC=CC(=C2)C3=NC4=CC=CC=C4N3 |
